About
87.29USD-1.09 -1.23%
Closed • Updated at 13:54 GMT+00:00Market Cap$152.04B
P/E Ratio24.32
Volume354.9K
Beta0.15
RSI41.35
Gross Margin52.84%
Abbott Laboratories — investor relations, events, news, and company updates on 6ix.
Latest News
May 18 2026
Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion
May 18 2026
Japan In Vitro Diagnostics Market Research Trends and Forecast Report 2026-2035 Featuring, Abbott Laboratories, Arkray, Danaher, Fujirebio, H.U., Roche Diagnostics, Sysmex, Tosoh
May 18 2026
Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo
May 14 2026
Abbott, Stringham & Lynch Announces Acquisition of Finance and Accounting Solutions Firm, ArightCo
May 13 2026
Australia Regenerative Medicine Market Research Trends and Forecasts Report 2026-2035 Featuring Prominent Players Such as Abbott Laboratories, Astellas Pharma, and Roche
Google Übersetzer